Artificial Intelligence in Oncology

Presented by:
David Liebovitz
Search for other papers by David Liebovitz in
Current site
Google Scholar
PubMed
Close
 MD
,
Randa M. Perkins
Search for other papers by Randa M. Perkins in
Current site
Google Scholar
PubMed
Close
 MD, MBA
, and
Irbaz Riaz
Search for other papers by Irbaz Riaz in
Current site
Google Scholar
PubMed
Close
 MBBS, MS, MBI
Moderated by:
Peter D. Stetson
Search for other papers by Peter D. Stetson in
Current site
Google Scholar
PubMed
Close
 MD, MA
Restricted access

A panel of experts in artificial intelligence (AI) and clinical informatics discussed the current applications and future potential of AI in oncology. The panelists shared insights into ongoing AI projects at their respective institutions, ranging from drug design and patient education to clinical decision support and administrative tasks. Key areas of focus included the use of AI for radiology and pathology, ambient listening during patient visits, and patient engagement through intelligent interfaces. The speakers also addressed the challenges of regulatory oversight, data quality, and the need for ethical and responsible AI design. The panel concluded that although AI has the potential to transform various aspects of oncology care, careful consideration must be given to patient preferences, clinical workflows, and validation of AI models in oncology-specific settings.

Disclosures: The presenters have disclosed no relevant financial relationships.

Correspondence: Peter D. Stetson, MD, MA, Memorial Sloan Kettering Cancer Center, 633 Third Avenue, Suite 220N, New York, NY 10017. Email: stetsonp@mskcc.org
  • Collapse
  • Expand

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 1375 1375 136
PDF Downloads 790 790 19
EPUB Downloads 0 0 0